| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $2.3M | +25.9% |
| SG&A Expense | $1.7M | +28.8% |
| Operating Income | -$4.1M | -27.1% |
| Net Income | -$1.4M | +53.6% |
| EPS (Basic) | -$0.01 | +50.0% |
| EPS (Diluted) | -$0.01 | +50.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $49K | +19.0% |
| Current Assets | $81K | +5.9% |
| Total Assets | $1.4M | +34.9% |
| Current Liabilities | $2.2M | +47.2% |
| Total Liabilities | $4.2M | -7.7% |
| Stockholders' Equity | -$2.8M | +20.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.0M | +37.3% |
| Capital Expenditures | $71K | -75.3% |
| Investing Cash Flow | -$116K | +63.9% |
| Financing Cash Flow | $1.1M | -35.6% |
| Free Cash Flow | -$1.1M | +43.1% |